Skip to main content
Premium Trial:

Request an Annual Quote

Arrayjet Closes Private Financing Round

NEW YORK (GenomeWeb) – Scottish microarray instrument maker Arrayjet today announced that it has closed a £650,000 ($867,773) private investment round.

Archangel Investors led the round, with additional investment from Scottish Enterprise.

Arrayjet said it would use the funds from the financing to expand its in-house consultancy service Arrayjet Advance, broaden its global footprint, and bring new products to market.

"This latest round of investment … will help Arrayjet capitalize on the global market demand for our technology, and accelerate the company's pace of product innovation," Arrayjet CEO Iain McWilliam said in a statement.

Last year, the company announced a contract with CDI Laboratories valued at more than $600,000. The year before, it signed a co-development agreement with Safeguard for food safety arrays.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more